DreamCIS, Inc. (KOSDAQ:223250)
South Korea
· Delayed Price · Currency is KRW 5,400.00
-70.00 (-1.28%)
At close: Mar 6, 2026
DreamCIS Revenue
DreamCIS had revenue of 16.52B KRW in the quarter ending September 30, 2025, a decrease of -9.22%. This brings the company's revenue in the last twelve months to 62.06B, up 9.11% year-over-year. In the year 2024, DreamCIS had annual revenue of 58.65B with 22.59% growth.
Revenue (ttm)
62.06B
Revenue Growth
+9.11%
P/S Ratio
2.00
Revenue / Employee
159.14M
Employees
390
Market Cap
123.87B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HLB bioStep | 71.47B |
| P&K Skin Research Center | 22.13B |
| C&R Research | 63.97B |
| WOOJUNG BIO | 37.12B |
| DT&CRO CO. | 44.36B |
| SLS BIO | 5.47B |
| Hyundai ADM Bio | 9.74B |
| BioInfra | 21.92B |